In this episode Ariel Katz, Co-Founder & CEO at H1 joins to discuss how AI can transform the way Pharma engages thought leaders.

Listen to discover: 

• A quick catch-up with Katz 
• Why healthcare, and more specifically Life Sciences/Pharma, tend to lag in adopting newer technologies like AI? 
• If the data we're receiving now is better, or if we just have a different way to apply it via the new tech
• H1's recent announcements about how how they are changing the game with new AI powered capabilities within the HCP Universe product
• The change management approach LS companies should employ to help Med Affairs and MSL move forward in this new era of AI and big data
• If Katz thinks it will make measuring activities, ROI, metrics, and impact for Medical Affairs more efficient and effective

Sponsored by: H1 (https://www.h1.co/)

To learn more about H1 please use the links below:

- Website - LinkedIn

Also, be sure to follow Slice of Healthcare on our social channels:

- Website - Facebook - LinkedIn - Twitter - YouTube - Newsletter

In this episode Alexandra Moens, Director of Product Marketing and Adam Wyckoff, Director of Product, Clinical Trials, at H1 join to discuss Divergent Diversity: Where the world is headed with health equity and diversity in clinical trials and bringing drugs to market. 

Listen to discover: 

• How Moens and Wyckoff have seen the terms diversity and health equity change and evolve in their own experiences
• How health equity is translated to clinical trials 
• What the biggest barrier to reaching diverse patient populations is
• How physicians and investigators, as well as social determinants, within communities and drug companies factor into this
• How data can mitigate or begin to combat this challenge when it comes to clinical trials or with bringing drugs to market

Sponsored by: H1 (https://www.h1.co/)

To learn more about H1 please use the links below:

- Website - LinkedIn

Also, be sure to follow Slice of Healthcare on our social channels:

- Website - Facebook - LinkedIn - Twitter - YouTube - Newsletter

Out guest: Robert Consalvo, Senior Director of Sales Engineering & Enablement at H1

In this episode we discuss: 

• Consalvo's background & role at H1
• In terms of medical affairs, pharma and life sciences - what Consalvo means by N.B.A, and what actions he's driving for his intended results?
• When talking about pharma - why the role of medical affairs is critical to the success of drug launch and development?
• What roadblocks Consalvo sees some organizations run up against when looking for their next best action? 
• When encountering these roadblocks, what’s the best way to pivot and score?

Sponsored by: H1 (https://www.h1.co/)

To learn more about H1 please use the links below:

- Website - LinkedIn

Also, be sure to follow Slice of Healthcare on our social channels:

- Website - Facebook - LinkedIn - Twitter - YouTube - Newsletter

Our guest: Anatoly Geyfman, VP of Medical Devices at H1

In this episode we discuss: 

• Geyfman's background 
• How Geyfman joined H1 by acquisition of his company Carevoyance, how he saw needs in the market that were not being met, and how H1 fit that vision
• How Geyfman views himself as a techno-optimist
• Why it’s even more critical for medical devices to reach underserved populations to achieve better health equity

Sponsored by: H1 (https://www.h1.co/)

To learn more about H1 please use the links below:

- Website - LinkedIn

Also, be sure to follow Slice of Healthcare on our social channels:

- Website - Facebook - LinkedIn - Twitter - YouTube - Newsletter

Our guest: Ariel Katz, CEO & Co-Founder at H1

In this episode we discuss: 
- Katz's background 
- Why he started H1
- H1's values and what they stand for in its brand and vision
- What the future of H1 innovation looks like

Sponsored by: H1 (https://www.h1.co/)

To learn more about H1 please use the links below:

- Website - LinkedIn

Also, be sure to follow Slice of Healthcare on our social channels:

- Website - Facebook - LinkedIn - Twitter - YouTube - Newsletter